Search

Epithelial Ovarian Cancer (EOC) is one of the leading causes of cancer-related deaths among women and is characterized by the diffusion of nodules or plaques from the ovary to the peritoneal surfaces. Conventional therapeutic options cannot eradicate the disease and show low efficacy against resistant tumor subclones. The treatment of liquids via cold atmospheric pressure plasma enables the production of plasma-activated liquids (PALs) containing reactive oxygen and nitrogen species (RONS) with selective anticancer activity. Thus, the delivery of RONS to cancer tissues by intraperitoneal washing with PALs might be an innovative strategy for the treatment of EOC. In this work, plasma-activated Ringer&rsquo, s Lactate solution (PA-RL) was produced by exposing a liquid substrate to a multiwire plasma source. Subsequently, PA-RL dilutions are used for the treatment of EOC, non-cancer and fibroblast cell lines, revealing a selectivity of PA-RL, which induces a significantly higher cytotoxic effect in EOC with respect to non-cancer cells.

Monocytes are involved in innate immune surveillance, establishment and resolution on inflammation, and can polarize versus M1 (pro-inflammatory) or M2 (anti-inflammatory) macrophages. The possibility to control and drive immune cells activity through plasma stimulation is therefore attractive. We focused on the effects induced by cold-atmospheric plasma on human primary monocytes and monocyte-derived macrophages. Monocytes resulted more susceptible than monocyte-derived macrophages to the plasma treatment as demonstrated by the increase in reactive oxygen (ROS) production and reduction of viability. Macrophages instead were not induced to produce ROS and presented a stable viability. Analysis of macrophage markers demonstrated a time-dependent decrease of the M1 population and a correspondent increase of M2 monocyte-derived macrophages (MDM). These findings suggest that plasma treatment may drive macrophage polarization towards an anti-inflammatory phenotype.

In this paper we developed an innovative, effective and rapid one-step approach to crosslink mucoadhesive gelatin films for buccal drug delivery. The method, which involves the application of non-equilibrium pressure plasma for 3 or 5 minutes/side, was compared with a classical approach based on the use of a chemical crosslinking agent, namely genipin. Econazole nitrate (ECN), an imidazole antifungal agent used for the treatment of skin infections and mucosal candidiasis, was selected as model drug. X-Ray Diffraction characterization performed on the drug-containing gelatin films revealed that ECN undergoes to a topotactic transformation into Econazole (EC) immediately after mixing with gelatin suggesting the occurrence of an acid-base reaction between drug and gelatin during film processing. Plasma treatment, as well as genipin crosslinking, did not provoke any further variation of EC structure. However, plasma exposure significantly improved films adhesiveness and allowed to reach mucoadhesive strength values more than double with respect to those obtained with genipin, ascribable to the presence of polar and hydrophilic groups on the plasma treated film’s surface. A residence time of at least 48 h was obtained by properly selecting the plasma exposure times. These results, together with the in-vitro data showing retention of antifungal efficacy against a strain of Candida albicans, demonstrated that plasma treatment was a valid and rapid alternative, easy to scale-up, to chemical crosslinking methods for the production of highly mucoadhesive gelatin-based films.

In the work, the feasibility of using atmospheric pressure non-equilibrium plasmas to clean the surface of a deteriorated 19th century daguerreotype has been examined and a proof-of-principle demonstration is given. The daguerreotype was treated by means of both a commercial plasma jet source (kINPen 09, Neoplas Tools GmbH) and a specially designed Dielectric Barrier Discharge (DBD) plasma source operated within a controlled volume at atmospheric pressure, by using a argon-hydrogen gas mixture (H2 content: 35% vol.) to remove corrosion products, without immersion of the substrate in solvents or chemicals. The effectiveness of plasma treatment in removing tarnishing products while preventing damage to the fragile image has been evaluated analysing the surface by means of scanning electron microscopy (SEM) with energy dispersive microprobe (EDS) for localized elemental analysis, micro-Raman and ATR-FTIR spectroscopy for phase identification.

Fully bio-based and biodegradable materials, such as polylactic acid (PLA) and microfibrillated cellulose (MFC), are considered in order to produce a completely renewable packaging solution for oxygen barrier applications, even at medium-high relative humidity (R.H.). Thin layers of MFC were coated on different PLA substrates by activating film surface with an atmospheric plasma treatment, leading to the fabrication of robust and transparent multilayer composite films, which were then characterized by different experimental techniques. UV transmission measurements confirmed the transparency of multilayer films (60% of UV transmission rate), while SEM micrographs showed the presence of a continuous, dense and defect free layer of MFC on PLA surface. Concerning the mechanical behavior of the samples, tensile tests revealed that the multilayer films significantly improved the stress at break value of neat PLA. Moreover, the oxygen barrier properties of the multilayer films were improved more than one order of magnitude compared to neat PLA film at 35 °C and 0% R.H. and the permeability values were maintained up to 60% R.H. The obtained materials therefore showed interesting properties for their possible use in barrier packaging applications as fully biodegradable solution, coupling two primarily incompatible matrices in a multilayer film with no need of any solvent or chemical.

Electrospun poly-l-lactic acid (PLLA) nanofiber mats carrying surface amine groups, previously introduced by nitrogen atmospheric pressure nonequilibrium plasma, are embedded into aqueous solutions of oligomeric acrylamide-end capped AGMA1, a biocompatible polyamidoamine with arg-gly-asp (RGD)-reminiscent repeating units. The resultant mixture is finally cured giving PLLA-AGMA1 hydrogel composites that absorb large amounts of water and, in the swollen state, are translucent, soft, and pliable, yet as strong as the parent PLLA mat. They do not split apart from each other when swollen in water and remain highly flexible and resistant, since the hydrogel portion is covalently grafted onto the PLLA nanofibers via the addition reaction of the surface amine groups to a part of the terminal acrylic double bonds of AGMA1 oligomers. Preliminary tested as scaffolds, the composites prove capable of maintaining short-term undifferentiated cultures of human pluripotent stem cells in feeder-free conditions.